Feeling better can be a powerful temptation to stop medication, especially when pain eases and daily life feels easier. For people living with ankylosing spondylitis, however, stopping disease-modifying antirheumatic drugs (DMARDs) or other prescribed treatments on your own can carry real risks. The disease is unpredictable: it can stay quiet for a while, then relapse or gradually worsen. That uncertainty is why medication decisions should always be guided by a physician.
Why stopping DMARDs suddenly is risky
Ankylosing spondylitis medications should never be stopped without medical supervision. Abruptly discontinuing DMARDs significantly increases the risk of a flare-up. Because ankylosing spondylitis can relapse even after good disease control, suddenly stopping treatment may allow inflammation to return, leading to renewed pain, stiffness, and potential joint damage.
- Unpredictable disease course: The condition may remain stable for months or years, but it can also relapse unexpectedly.
- Higher relapse risk: Studies and clinical experience show relapses commonly occur within 1 to 2 years if treatment is stopped or reduced inappropriately.
- Potential for lasting harm: Repeated uncontrolled inflammation increases the risk of structural changes and functional decline.
How doctors decide when to reduce medication
Medication adjustment is a medical decision. Rheumatologists assess several factors before recommending a dose reduction or tapering plan. Those factors include:
- Pain levels — Are symptoms truly minimal or absent over a sustained period?
- Functional ability — Can you perform daily activities without limitation?
- Disease activity scores — Objective measures and indices help quantify inflammation and control.
- Physical mobility — Spine and joint mobility examinations reveal ongoing disease impact.
- Imaging and labs — Blood tests and imaging may show subclinical inflammation even when pain is low.
▶
What safe medication reduction looks like
When reduction is appropriate, it should be gradual, planned, and monitored. Typical elements of a safe approach include:
- A clear treatment goal and timeline agreed with your doctor.
- Stepwise dose reductions rather than abrupt stop.
- Regular follow-up appointments and repeat assessments of symptoms, function, and blood tests.
- A plan to quickly reinstate or escalate therapy if signs of relapse appear.
Practical steps for people living with ankylosing spondylitis
- Keep regular follow-ups with your rheumatologist even when you feel well.
- Do not stop or change doses of DMARDs, biologics, or other prescribed drugs without talking to your physician.
- Track symptoms and function. Note new pain, morning stiffness, reduced mobility, or fatigue and report these promptly.
- Maintain non-drug measures: physiotherapy, exercises for spinal mobility and posture, smoking cessation, and a healthy lifestyle all support long-term control.
- Discuss special situations—such as planning pregnancy, major surgery, or infections—with your care team before making any medication changes.
When to contact your doctor immediately
Reach out promptly if you notice:
- Return of persistent back pain or new joint pain.
- Worsening morning stiffness or decreased mobility.
- New systemic symptoms such as fever or unexplained fatigue.
Takeaway
Reduced pain is a welcome sign, but it is not a green light to stop medication on your own. Ankylosing spondylitis can relapse, sometimes within 1 to 2 years of stopping treatment. Medication changes should be made only under the guidance of a rheumatologist, using a gradual, monitored plan that balances symptom control and long-term joint health. Staying connected with your care team, keeping routine monitoring, and combining medical treatment with physical therapy and healthy habits gives you the best chance of sustained control.